Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway-Reference-Cited by-同舟云学术

Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway

Published:2018-10-04 Issue:sup3 Volume:46 Page:S707-S716
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Mao Shuai¹²,Wang Lei²,Chen Peipei¹²,Lan Yong³,Guo Rui⁴,Zhang Minzhou¹²

Affiliation:

1. Key Discipline of Integrated Chinese and Western Medicine, Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China;

2. AMI Key laboratory of Chinese Medicine in Guangzhou, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China;

3. Beogene Biotech (Guangzhou) CO., LTD, Guangzhou, China;

4. Department of Biomedical Engineering, Jinan University, Guangzhou, China

Funder

National Science Foundation

National Basic Research Program of China

Science Foundation of Guangdong Province

Guangdong special support program for high-level talents

Medical Science and Technology Research Foundation of Guangdong Province

Science and Technology Program of Guangzhou

Pearl River S&T Nova Program of Guangzhou

Science and Technology Project of Guangdong province

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2018.1508028

Reference32 articles.

1. Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction

2. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy

3. Cardiovascular actions and therapeutic potential of tanshinone IIA

4. Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB

5. Tanshinone IIA inhibits myocardial remodeling induced by pressure overload via suppressing oxidative stress and inflammation: Possible role of silent information regulator 1

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the therapeutic potential and nanotechnological approaches for the delivery of tanshinone IIA;Pharmacological Research - Modern Chinese Medicine;2024-09

2. Advanced Nanomedicine Approaches for Myocardial Infarction Treatment;International Journal of Nanomedicine;2024-06

3. The development of nanocarriers for natural products;WIREs Nanomedicine and Nanobiotechnology;2024-05

4. Optimized new Shengmai powder ameliorates myocardial fibrosis in rats with heart failure by inhibition of the MAPK signaling pathway;Journal of Ethnopharmacology;2024-01

5. Exploring the potential mechanism of Simiao Yongan decoction in the treatment of diabetic peripheral vascular disease based on network pharmacology and molecular docking technology;Medicine;2023-12-29